Hemab Therapeutics Holdings Inc (COAG)

Oct 15, 2026

Hemab Therapeutics (NASDAQ:COAG) Stock Price Up 8.4%Here's What Happened - MarketBeat

Oct 15, 2026

Oct 06, 2026

Hemab Therapeutics (NASDAQ:COAG) Stock Price Down 7.5%What's Next? - MarketBeat

Oct 06, 2026

Oct 01, 2026

Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 01, 2026

Sep 30, 2026

Hemab Therapeutics (NASDAQ:COAG) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat

Sep 30, 2026

Sep 28, 2026

Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount? - Yahoo Finance

Sep 28, 2026

Sep 28, 2026

Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount? - Yahoo Finance UK

Sep 28, 2026

Sep 27, 2026

76,900 Shares in Hemab Therapeutics Holdings, Inc. $COAG Bought by State Street Corp - MarketBeat

Sep 27, 2026

Sep 26, 2026

Form 4 Hemab Therapeutics Holdings For: 25 September - Investing.com India

Sep 26, 2026

Sep 25, 2026

Form 4 Hemab Therapeutics Holdings For: 25 September By Investing.com - Investing.com Canada

Sep 25, 2026

Sep 25, 2026

Form 4 Hemab Therapeutics Holdings For: 25 September By Investing.com - Investing.com UK

Sep 25, 2026

Sep 25, 2026

Director Walbert Keli's option carries a $35.72 exercise price at Hemab Therapeutics (COAG). - stocktitan.net

Sep 25, 2026

Sep 25, 2026

Hemab Therapeutics Holdings, Inc. (COAG) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 25, 2026

Sep 23, 2026

Can Hemab Therapeutics Holdings (COAG) Justify Its Valuation After Russell Index Inclusion? - Simply Wall Street

Sep 23, 2026

Sep 21, 2026

Hemab Therapeutics (NASDAQ:COAG) Shares Down 5.7%What's Next? - MarketBeat

Sep 21, 2026

Sep 20, 2026

Hemab Therapeutics Holdings (Nasdaq:COAG)Stock Analysis - simplywall.st

Sep 20, 2026

Sep 17, 2026

Hemab Therapeutics Holdings, Inc.(NasdaqGS:COAG) added to Russell 3000 Value Benchmark - marketscreener.com

Sep 17, 2026

Sep 17, 2026

Heavy menstrual bleeding affects 1 in 3 women. Hemab begins testing a new treatment. - Stock Titan

Sep 17, 2026

Sep 16, 2026

Hemab Therapeutics (NASDAQ:COAG) Shares Up 7.6%Time to Buy? - MarketBeat

Sep 16, 2026

Sep 11, 2026

Opaleye Management Inc. Makes New Investment in Hemab Therapeutics Holdings, Inc. $COAG - MarketBeat

Sep 11, 2026

Sep 10, 2026

Hemab Therapeutics (NASDAQ:COAG) Trading Down 6.8%What's Next? - MarketBeat

Sep 10, 2026

Sep 07, 2026

Citadel Advisors LLC Takes Position in Hemab Therapeutics Holdings, Inc. $COAG - MarketBeat

Sep 07, 2026

Sep 06, 2026

Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Sep 06, 2026

Sep 03, 2026

Braidwell LP Purchases New Shares in Hemab Therapeutics Holdings, Inc. $COAG - MarketBeat

Sep 03, 2026

Aug 21, 2026

Biopharma IPO class of 2026: share price up 66% on average - BioWorld News

Aug 21, 2026

Aug 20, 2026

Hemab Therapeutics (NASDAQ:COAG) Trading Down 8.4%Here's What Happened - MarketBeat

Aug 20, 2026

Aug 20, 2026

AppLovin vs. CoreWeave: What Recent Revenue Trends Tell Investors - Yahoo Finance

Aug 20, 2026

Aug 18, 2026

Capital International Investors Establishes New Position in Hema - GuruFocus

Aug 18, 2026

Aug 14, 2026

Novo Holdings A/S (COAG) discloses 9.0% beneficial stake in Hemab Therapeutics - Stock Titan

Aug 14, 2026

Aug 14, 2026

Avoro, Aghazadeh report 7.06% Hemab Therapeutics (COAG) ownership stake - Stock Titan

Aug 14, 2026

Aug 13, 2026

20 Years of Prix Galien USA Brings a New Nominee Class—Who Wins? - Stock Titan

Aug 13, 2026

Aug 13, 2026

HC Wainwright Cuts Earnings Estimates for Hemab Therapeutics - MarketBeat

Aug 13, 2026

Aug 12, 2026

Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $64 - Moomoo

Aug 12, 2026

Aug 12, 2026

Hemab Therapeutics (NASDAQ:COAG) Hits New 52-Week High After Analyst Upgrade - MarketBeat

Aug 12, 2026

Aug 12, 2026

Hemab Therapeutics (COAG): Capital International Investors discloses 7.7% ownership - Stock Titan

Aug 12, 2026

Aug 12, 2026

Hemab Therapeutics stock price target raised to $60 by H.C. Wainwright - Investing.com Canada

Aug 12, 2026

Aug 12, 2026

Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Aug 12, 2026

Aug 12, 2026

COAG SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus

Aug 12, 2026

Aug 11, 2026

FMR LLC Acquires Stake in Hemab Therapeutics Holdings Inc (COAG) - GuruFocus

Aug 11, 2026

Aug 11, 2026

H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $60 - Moomoo

Aug 11, 2026

Aug 11, 2026

Hemab Therapeutics Reports Q2 2026 Financials and Pipeline Progress in Latest 10-Q Filing - Kalkine Media

Aug 11, 2026

Aug 11, 2026

Hemab Therapeutics (COAG) widens loss but builds $457.5M cash war chest - Stock Titan

Aug 11, 2026

Aug 11, 2026

Hemab Therapeutics (NASDAQ:COAG) Price Target Raised to $60.00 at HC Wainwright - MarketBeat

Aug 11, 2026

Aug 11, 2026

Wedbush Adjusts Price Target on Hemab Therapeutics to $64 From $55, Keeps Outperform Rating - marketscreener.com

Aug 11, 2026

Aug 11, 2026

Form 8K Hemab Therapeutics Holdings For: 11 August By Investing.com - Investing.com South Africa

Aug 11, 2026

Aug 11, 2026

Hemab Therapeutics Gains FDA Backing to Advance Sutacimig Into Phase 3 Trial for Glanzmann Thrombasthenia - Minichart

Aug 11, 2026

Aug 11, 2026

Form 8K Hemab Therapeutics Holdings For: 11 August By Investing.com - Investing.com Nigeria

Aug 11, 2026

Aug 11, 2026

Hemab Therapeutics' Q2 Net Loss Narrows - marketscreener.com

Aug 11, 2026

Aug 11, 2026

Form 8K Hemab Therapeutics Holdings For: 11 August By Investing.com - Investing.com Canada

Aug 11, 2026

Aug 11, 2026

Earnings Flash (COAG) Hemab Therapeutics Posts Q2 Net Loss $0.80 a Share, vs. FactSet Est of $0.56 Loss - marketscreener.com

Aug 11, 2026

Aug 11, 2026

Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

Aug 11, 2026